Research programme: HSPPC-70-I - Antigenics
Alternative Names: HSPPC-70-ILatest Information Update: 30 Aug 2006
At a glance
- Originator Antigenics
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections; Tuberculosis
Most Recent Events
- 30 Aug 2006 Discontinued - Preclinical for Bacterial infections in USA (unspecified route)
- 30 Aug 2006 Discontinued - Preclinical for Tuberculosis in USA (unspecified route)
- 19 Oct 2005 Preclinical trials as a delivery aid in Tuberculosis vaccine in USA